05:44 AM EDT, 06/26/2024 (MT Newswires) -- Anew Medical ( WENA ) said Wednesday that it received a patent in Europe for the use of its Klotho gene sequence and gene delivery systems for the treatment of diminished cognition, memory loss, dementia, and other neurodegenerative diseases.

The company said the product's key intellectual property asset is covered under its exclusive worldwide license deal with Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Spain.

Anew Medical ( WENA ) it has also patent approval in China and Hong Kong, and that it plans to start product development and further expand its intellectual property portfolios into Asian markets this year.

Price: 1.6200, Change: -0.03, Percent Change: -1.82